A citation-based method for searching scientific literature

Jacqueline M Anderson, Alvaro Cerda, Mario H Hirata, Alice C Rodrigues, Egidio L Dorea, Marcia M S Bernik, Marcelo C Bertolami, Andre A Faludi, Rosario D C Hirata. J Clin Lipidol 2014
Times Cited: 21







List of co-cited articles
165 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Mutations in PCSK9 cause autosomal dominant hypercholesterolemia.
Marianne Abifadel, Mathilde Varret, Jean-Pierre Rabès, Delphine Allard, Khadija Ouguerram, Martine Devillers, Corinne Cruaud, Suzanne Benjannet, Louise Wickham, Danièle Erlich,[...]. Nat Genet 2003
52

Differential effects of PCSK9 loss of function variants on serum lipid and PCSK9 levels in Caucasian and African Canadian populations.
Janice Mayne, Teik Chye Ooi, Angela Raymond, Marion Cousins, Lise Bernier, Thilina Dewpura, Francine Sirois, Majambu Mbikay, Jean Davignon, Michel Chrétien. Lipids Health Dis 2013
43
52

A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol.
Ingrid K Kotowski, Alexander Pertsemlidis, Amy Luke, Richard S Cooper, Gloria L Vega, Jonathan C Cohen, Helen H Hobbs. Am J Hum Genet 2006
391
42

Sequence variations in PCSK9, low LDL, and protection against coronary heart disease.
Jonathan C Cohen, Eric Boerwinkle, Thomas H Mosley, Helen H Hobbs. N Engl J Med 2006
38

Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9.
Jonathan Cohen, Alexander Pertsemlidis, Ingrid K Kotowski, Randall Graham, Christine Kim Garcia, Helen H Hobbs. Nat Genet 2005
899
33

PCSK9 R46L, low-density lipoprotein cholesterol levels, and risk of ischemic heart disease: 3 independent studies and meta-analyses.
Marianne Benn, Børge G Nordestgaard, Peer Grande, Peter Schnohr, Anne Tybjaerg-Hansen. J Am Coll Cardiol 2010
225
28


The PCSK9 gene R46L variant is associated with lower plasma lipid levels and cardiovascular risk in healthy U.K. men.
Marileia Scartezini, Christina Hubbart, Ros A Whittall, Jackie A Cooper, Andrew H W Neil, Steve E Humphries. Clin Sci (Lond) 2007
70
28

Genetic variants in PCSK9 affect the cholesterol level in Japanese.
Keisuke Shioji, Toshifumi Mannami, Yoshihiro Kokubo, Nozomu Inamoto, Shuichi Takagi, Yoichi Goto, Hiroshi Nonogi, Naoharu Iwai. J Hum Genet 2004
69
28

Effects of PCSK9 variants on common carotid artery intima media thickness and relation to ApoE alleles.
Giuseppe Danilo Norata, Katia Garlaschelli, Liliana Grigore, Sara Raselli, Simona Tramontana, Fiorella Meneghetti, Roberto Artali, Davide Noto, Angelo Baldassare Cefalù, Gherardo Buccianti,[...]. Atherosclerosis 2010
58
28

The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation.
Nabil G Seidah, Suzanne Benjannet, Louise Wickham, Jadwiga Marcinkiewicz, Stephanie Belanger Jasmin, Stefano Stifani, Ajoy Basak, Annik Prat, Michel Chretien. Proc Natl Acad Sci U S A 2003
805
28


NARC-1/PCSK9 and its natural mutants: zymogen cleavage and effects on the low density lipoprotein (LDL) receptor and LDL cholesterol.
Suzanne Benjannet, David Rhainds, Rachid Essalmani, Janice Mayne, Louise Wickham, Weijun Jin, Marie-Claude Asselin, Josée Hamelin, Mathilde Varret, Delphine Allard,[...]. J Biol Chem 2004
452
23

Structural and biophysical studies of PCSK9 and its mutants linked to familial hypercholesterolemia.
David Cunningham, Dennis E Danley, Kieran F Geoghegan, Matthew C Griffor, Julie L Hawkins, Timothy A Subashi, Alison H Varghese, Mark J Ammirati, Jeffrey S Culp, Lise R Hoth,[...]. Nat Struct Mol Biol 2007
316
23

Genetic variation at the PCSK9 locus moderately lowers low-density lipoprotein cholesterol levels, but does not significantly lower vascular disease risk in an elderly population.
Eliana Polisecki, Inga Peter, Michele Robertson, Alex D McMahon, Ian Ford, Christopher Packard, James Shepherd, J Wouter Jukema, Gerard J Blauw, Rudi G J Westendorp,[...]. Atherosclerosis 2008
49
23

Mutations and polymorphisms in the proprotein convertase subtilisin kexin 9 (PCSK9) gene in cholesterol metabolism and disease.
Marianne Abifadel, Jean-Pierre Rabès, Martine Devillers, Arnold Munnich, Danièle Erlich, Claudine Junien, Mathilde Varret, Catherine Boileau. Hum Mutat 2009
186
23


Longitudinal association of PCSK9 sequence variations with low-density lipoprotein cholesterol levels: the Coronary Artery Risk Development in Young Adults Study.
Chiang-Ching Huang, Myriam Fornage, Donald M Lloyd-Jones, Gina S Wei, Eric Boerwinkle, Kiang Liu. Circ Cardiovasc Genet 2009
63
19

The PCSK9 gene E670G polymorphism affects low-density lipoprotein cholesterol levels but is not a risk factor for coronary artery disease in ethnic Chinese in Taiwan.
Lung-An Hsu, Ming-Sheng Teng, Yu-Lin Ko, Chi-Jen Chang, Semon Wu, Chun-Li Wang, Chiao-Feng Hu. Clin Chem Lab Med 2009
29
19

A mutation in PCSK9 causing autosomal-dominant hypercholesterolemia in a Utah pedigree.
Kirsten M Timms, Susanne Wagner, Mark E Samuels, Kristian Forbey, Howard Goldfine, Srikanth Jammulapati, Mark H Skolnick, Paul N Hopkins, Steve C Hunt, Donna M Shattuck. Hum Genet 2004
245
19

Effect of E670G Polymorphism in PCSK9 Gene on the Risk and Severity of Coronary Heart Disease and Ischemic Stroke in a Tunisian Cohort.
Afef Slimani, Yahia Harira, Imen Trabelsi, Walid Jomaa, Faouzi Maatouk, Khaldoun Ben Hamda, Mohamed Naceur Slimane. J Mol Neurosci 2014
30
19

Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9.
Shirya Rashid, David E Curtis, Rita Garuti, Norma N Anderson, Yuriy Bashmakov, Y K Ho, Robert E Hammer, Young-Ah Moon, Jay D Horton. Proc Natl Acad Sci U S A 2005
517
19

Genetic and metabolic determinants of plasma PCSK9 levels.
Susan G Lakoski, Thomas A Lagace, Jonathan C Cohen, Jay D Horton, Helen H Hobbs. J Clin Endocrinol Metab 2009
349
19

Plasma PCSK9 concentrations correlate with LDL and total cholesterol in diabetic patients and are decreased by fenofibrate treatment.
Gilles Lambert, Nicolas Ancellin, Francesca Charlton, Daniel Comas, Julia Pilot, Anthony Keech, Sanjay Patel, David R Sullivan, Jeffrey S Cohn, Kerry-Anne Rye,[...]. Clin Chem 2008
137
19


Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins.
Iris Postmus, Stella Trompet, Harshal A Deshmukh, Michael R Barnes, Xiaohui Li, Helen R Warren, Daniel I Chasman, Kaixin Zhou, Benoit J Arsenault, Louise A Donnelly,[...]. Nat Commun 2014
146
19

The LDL receptor.
Joseph L Goldstein, Michael S Brown. Arterioscler Thromb Vasc Biol 2009
692
19

Healthy individuals carrying the PCSK9 p.R46L variant and familial hypercholesterolemia patients carrying PCSK9 p.D374Y exhibit lower plasma concentrations of PCSK9.
Steve E Humphries, R Dermot G Neely, Roslyn A Whittall, Jason S Troutt, Robert J Konrad, Marileia Scartezini, Ka Wah Li, Jackie A Cooper, Jayshree Acharya, Andrew Neil. Clin Chem 2009
35
19


Evidence for effect of mutant PCSK9 on apolipoprotein B secretion as the cause of unusually severe dominant hypercholesterolaemia.
Xi-Ming Sun, Emily R Eden, Isabella Tosi, Clare K Neuwirth, David Wile, Rossi P Naoumova, Anne K Soutar. Hum Mol Genet 2005
118
14


The proprotein convertase subtilisin/kexin type 9 gene E670G polymorphism and serum lipid levels in the Guangxi Bai Ku Yao and Han populations.
Lynn Htet Htet Aung, Rui-Xing Yin, Lin Miao, Xi-Jiang Hu, Ting-Ting Yan, Xiao-Li Cao, Dong-Feng Wu, Qing Li, Shang-Ling Pan, Jin-Zhen Wu. Lipids Health Dis 2011
38
14

Effects of PCSK9 genetic variants on plasma LDL cholesterol levels and risk of premature myocardial infarction in the Italian population.
Ilaria Guella, Rosanna Asselta, Diego Ardissino, Pier Angelica Merlini, Flora Peyvandi, Sekar Kathiresan, Pier Mannuccio Mannucci, Marco Tubaro, Stefano Duga. J Lipid Res 2010
34
14

Proprotein convertase subtilisin/kexin type 9 (PCSK9) gene is a risk factor of large-vessel atherosclerosis stroke.
Shérine Abboud, Pekka J Karhunen, Dieter Lütjohann, Sirkka Goebeler, Teemu Luoto, Silvia Friedrichs, Terho Lehtimaki, Massimo Pandolfo, Reijo Laaksonen. PLoS One 2007
51
14

Binding of proprotein convertase subtilisin/kexin type 9 to epidermal growth factor-like repeat A of low density lipoprotein receptor decreases receptor recycling and increases degradation.
Da-Wei Zhang, Thomas A Lagace, Rita Garuti, Zhenze Zhao, Meghan McDonald, Jay D Horton, Jonathan C Cohen, Helen H Hobbs. J Biol Chem 2007
540
14

Proprotein convertase subtilisin/kexin type 9 gene E670G polymorphism interacts with alcohol consumption to modulate serum lipid levels.
Lynn Htet Htet Aung, Rui-Xing Yin, Dong-Feng Wu, Xiao-Li Cao, Xi-Jiang Hu, Lin Miao. Int J Med Sci 2013
14
21

Common and low-frequency genetic variants in the PCSK9 locus influence circulating PCSK9 levels.
Ekaterina Chernogubova, Rona Strawbridge, Hovsep Mahdessian, Anders Mälarstig, Sergey Krapivner, Bruna Gigante, Mai-Lis Hellénius, Ulf de Faire, Anders Franco-Cereceda, Ann-Christine Syvänen,[...]. Arterioscler Thromb Vasc Biol 2012
44
14

Molecular characterization of loss-of-function mutations in PCSK9 and identification of a compound heterozygote.
Zhenze Zhao, Yetsa Tuakli-Wosornu, Thomas A Lagace, Lisa Kinch, Nicholas V Grishin, Jay D Horton, Jonathan C Cohen, Helen H Hobbs. Am J Hum Genet 2006
439
14

The proprotein convertase PCSK9 induces the degradation of low density lipoprotein receptor (LDLR) and its closest family members VLDLR and ApoER2.
Steve Poirier, Gaetan Mayer, Suzanne Benjannet, Eric Bergeron, Jadwiga Marcinkiewicz, Nasha Nassoury, Harald Mayer, Johannes Nimpf, Annik Prat, Nabil G Seidah. J Biol Chem 2008
306
14

Statins upregulate PCSK9, the gene encoding the proprotein convertase neural apoptosis-regulated convertase-1 implicated in familial hypercholesterolemia.
Geneviève Dubuc, Ann Chamberland, Hanny Wassef, Jean Davignon, Nabil G Seidah, Lise Bernier, Annik Prat. Arterioscler Thromb Vasc Biol 2004
455
14


Rosuvastatin, proprotein convertase subtilisin/kexin type 9 concentrations, and LDL cholesterol response: the JUPITER trial.
Zuhier Awan, Nabil G Seidah, Jean G MacFadyen, Suzanne Benjannet, Daniel I Chasman, Paul M Ridker, Jacques Genest. Clin Chem 2012
96
14

PCSK9 is a critical regulator of the innate immune response and septic shock outcome.
Keith R Walley, Katherine R Thain, James A Russell, Muredach P Reilly, Nuala J Meyer, Jane F Ferguson, Jason D Christie, Taka-aki Nakada, Chris D Fjell, Simone A Thair,[...]. Sci Transl Med 2014
211
14

Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog.
P T Kovanen, D W Bilheimer, J L Goldstein, J J Jaramillo, M S Brown. Proc Natl Acad Sci U S A 1981
449
14

Both rare and common variants in PCSK9 influence plasma low-density lipoprotein cholesterol level in American Indians.
Ching-Wei Tsai, Kari E North, Adrienne Tin, Karin Haack, Nora Franceschini, V Saroja Voruganti, Sandy Laston, Ying Zhang, Lyle G Best, Jean W MacCluer,[...]. J Clin Endocrinol Metab 2015
16
18

Pharmacogenetic study of apolipoprotein E, cholesteryl ester transfer protein and hepatic lipase genes and simvastatin therapy in Brazilian subjects.
Marilu Fiegenbaum, Fabiano R da Silveira, Cézar R Van der Sand, Luiz Carlos Van der Sand, Maria E W Ferreira, Renan C Pires, Mara H Hutz. Clin Chim Acta 2005
30
14

Comprehensive whole-genome and candidate gene analysis for response to statin therapy in the Treating to New Targets (TNT) cohort.
John F Thompson, Craig L Hyde, Linda S Wood, Sara A Paciga, David A Hinds, David R Cox, G Kees Hovingh, John J P Kastelein. Circ Cardiovasc Genet 2009
139
14

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.
C Baigent, L Blackwell, J Emberson, L E Holland, C Reith, N Bhala, R Peto, E H Barnes, A Keech, J Simes,[...]. Lancet 2010
14




Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.